Delivery Order SPE2DR25D1100-SPE2DR26FDD3U
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency for the supply of Eucrisa 2% Ointment (60 gm) with a ceiling value of $1,031.86. The contract was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, under firm fixed-price terms with no set-aside designation. This delivery order was issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,597.41 to Amerisourcebergen Drug Corp on January 21, 2026, for the supply of Eucrisa 2% Ointment in 60-gram quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 22, 2026, and represents a task order executed against a larger contract vehicle. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,467.27 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment (60gm) on December 2, 2025, with completion required by December 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor's corporate office location in Conshohocken, Pennsylvania also serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,222.76 to AmerisourceBergen Drug Corp for the supply of Eucrisa 2% Ointment in 60-gram units. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with a completion deadline of December 2, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single...
- This delivery order, valued at $1,538.37, awards AmerIsourceBergen Drug Corp the supply of Eucrisa 2% Ointment in 60-gram quantities under a Defense Logistics Agency (DLA) contract with a firm fixed price structure. The award was made on January 21, 2026, with an ultimate completion date of January 22, 2026, and carries no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, which serves as the corporate headquarters for...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company, to provide a specialty branded pharmaceutical product - Eucrisa 2% Ointment 60GM. The award, valued at $7,349.06, has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,991.09 contract is for the delivery of Eucrisa 2% ointment, a prescription skin treatment medication, with a completion date of December 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The federal contract award is for the delivery of Eucrisa 2% ointment, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,384.68 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.91 to AmerisourceBergen Drug Corp for EUCRISA 2% Ointment in 60-gram units. This firm fixed-price, non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,664.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 grams of EUCRISA 2% Ointment, with an ultimate completion date of January 7, 2026. This competitively awarded, non-set-aside contract was issued on January 6, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDD3UDelivery Order
The Defense Logistics Agency awarded a $3,070.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on February 4, 2026, for the supply of Eucrisa 2% ointment in 60-gram units. This non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle with DLA. This contract exemplifies the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support military healthcare systems worldwide, including medications for dermatological conditions, chronic diseases, and other medical needs. The parent company, Cencora, Inc., operates under the AmerisourceBergen brand and maintains significant federal contracting relationships, including a $999,999,999.00 IDC with DLA extending through December 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 2/3/26 |